Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0OQXQI
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
P2-528mAb
|
|||||
| Synonyms |
P2-528mAb
Click to Show/Hide
|
|||||
| Organization |
Commonwealth Scientific and Industrial Research Organization; University of Queensland.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1
|
|||||
| Structure |
|
|||||
| Antibody Name |
528mAb
|
Antibody Info | ||||
| Antigen Name |
Epidermal growth factor receptor (EGFR)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through nucleophilic lysines.
|
|||||
ADC-specific functional property(2027 Update)
Binding Affinity
| Dissocation Constant (Kd) | Binding Target | Description | Reference |
|---|---|---|---|
| 3.0±0.1 nM |
EGFR
|
Surface plasmon resonance (SPR)
|
[1]
|
References